Article Text

Download PDFPDF
Endoscopic ultrasound in the follow up and response assessment of patients with primary gastric lymphoma
  1. A Püspök1,
  2. M Raderer2,
  3. A Chott3,
  4. B Dragosics4,
  5. A Gangl1,
  6. R Schöfl1
  1. 1Division of Gastroenterology and Hepatology, Department of Internal Medicine IV, AKH, University of Vienna, Vienna, Austria
  2. 2Division of Oncology, Department of Internal Medicine I, AKH, University of Vienna, Vienna, Austria
  3. 3Department of Clinical Pathology, AKH, University of Vienna, Vienna, Austria
  4. 4Gesundheitszentrum Wien-Süd, Wiener Gebietskrankenkasse (WGKK), Vienna, Austria
  1. Correspondence to:
    Dr A Püspök, Department of Internal Medicine IV, AKH, Division of Gastroenterology and Hepatology, Waehringergürtel 18-20, A-1090 Vienna, Austria;
    andreas.puespoek{at}akh-wien.ac.at

Abstract

Background: Endoscopic ultrasound (EUS) is considered the best technique for local staging of primary gastric lymphomas. Its role in the follow up of patients with gastric lymphoma following organ conserving strategies has not been established.

Aim: To compare endosonographic response assessment with results of histological evaluation.

Patients and methods: Thirty three patients with primary gastric lymphomas underwent pretreatment EUS and were followed endosonographically every 3–6 months after administration of organ conserving treatment modalities. A wall thickness of ≤4 mm with preserved five layer structure and the absence of suspicious lymph nodes was defined as endosonographic remission. Decrease in wall thickness, increase in echogenicity, and regression of lymph nodes were tested for their value to predict histological remission.

Results: A total of 158 endosonographies were performed (median 4; range 2–12). Within a median follow up period of 15 months (range 3–48), 27 (82%) patients achieved complete histological remission while endosonographic remission was found in 21 (64%) patients. Eighteen patients achieved both forms of remission, with endosonographic remission occurring later (35.1 (11–212.9) weeks v 17.6 (11–97.9) weeks; median (range); p<0.02) than histological remission. A further three patients demonstrated a false negative remission on EUS. Histological relapse was paralleled by endosonographic relapse in only one of five patients. None of the tested endosonographic parameters was able to predict histological remission.

Conclusions: In view of the inferior accuracy of EUS when compared with histology, gastroscopy with biopsy seems sufficient for the routine follow up of patients with gastric lymphoma.

  • endosonography
  • mucosa associated lymphoid tissue
  • gastric lymphoma
  • MALT, mucosa associated lymphoid tissue
  • EUS, endoscopic ultrasound
  • DLBCL, diffuse large B cell lymphoma

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

Linked Articles